Dong Wang

Dong Wang

Auto-generated profile, based on publicly available information

Dong Wang


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2026 in Communications Biology
Verified
Journal Article
Open access
PDF file
YLYuyuan Li
Yuyuan Li
JYJing Yu
Jing Yu
QLQi Li
Qi Li
SGShibo Gao
Shibo Gao
JHJia Hu
Jia Hu
YCYang Chen
Yang Chen
Escherichia fergusonii is an emerging food-borne opportunistic pathogen that disrupts gut homeostasis and exacerbates the severity of other organ diseases. However, the effects of gut colonization by E. fergusonii on the gut-lung axis remain unclear. Here we show that the abundance of Escherichia increases in microbiota-depleted mice and is enriches in patients with K. pneumoniae-associated pneumonia. Both alterations show a statistically significant correlation with the severity of lung infection. In the murine model, gut colonization by E. fergusonii induces specific gut dysbiosis, decreases intestinal and pulmonary acetate levels, and exacerbates carbapenem-resistant K. pneumoniae-induced pneumonia. Notably, fecal microbiota transplantation and acetate administration restore immune responses, ameliorate gut dysbiosis, increase acetate concentrations in intestinal and pulmonary tissues, and improve disease outcomes in mice with pneumonia. This study demonstrates that E. fergusonii-induced gut dysbiosis modifies the gut-lung immune axis in resistant K. pneumoniae-induced pneumonia and proposes a potential intervention strategy involving microbiota-derived acetate.

21 August 2026 in iScience
Verified
Journal Article
Open access
YWYicheng Wang
Yicheng Wang
JLJixiang Li
Jixiang Li
XDXuxu Du
Xuxu Du
WLWutang Li
Wutang Li
DWDong Wang
Dong Wang
YLYuyuan Li
Yuyuan Li
The tumor microenvironment (TME) contains a diverse intratumoral microbiota (ITM) governing cancer onset, progression, and therapeutic response. This review compares ITM profiles of colorectal and lung cancer, two anatomically distinct malignancies linked via the gut-lung axis, and summarizes microbial detection strategies ranging from cultivation and sequencing to spatial and single-cell technologies. Oral pathobionts such as Fusobacterium nucleatum, Streptococcus, and Veillonella accumulate in both cancers, promoting tumorigenesis through chronic inflammation, immune evasion, genotoxic insults, metabolic reprogramming, and facilitating colorectal cancer lung metastasis via venous drainage and systemic dissemination. Microbial signatures in stool, saliva, blood, and tumor tissue offer non-invasive tools for detection, prognosis, and prediction of immunotherapy resistance, while antibiotics, fecal microbiota transplantation, and engineered live biotherapeutics offer strategies to remodel the TME. This synthesis positions the gut-lung axis as a systemic driver of metastasis and outlines a route toward precision microbiome-based diagnostics and therapeutics.